iShares Core MSCI EM IMI UCITS ETF (EIMI) Review: Emerging Markets Done Properly

By Kestutis Balciunas·Reviewed August 26, 2026

EIMI is the iShares Core MSCI Emerging Markets IMI UCITS ETF: ISIN IE00BKM4GZ66, 0.18% a year, EUR 37,658m under management, Irish-domiciled, accumulating, physically replicated, running since 30 May 2014. It holds over 3,000 emerging-market companies across large, mid and small caps, and it is one of the largest EM funds available to European investors (justETF, 26 August 2026).

The iShares Core MSCI EM IMI UCITS ETF (EIMI, ISIN IE00BKM4GZ66) is the standard answer to a question every European index investor eventually asks: how do I own emerging markets without picking countries? EIMI’s answer is maximal: the IMI (Investable Market Index) version of MSCI Emerging Markets covers large, mid and small caps — over 3,000 stocks across two dozen countries — for a 0.18% TER in the familiar Irish accumulating wrapper.

I hold the view that if you buy emerging markets at all, this breadth-first approach is the right way to do it. This review explains what IMI adds over the plain EM index, what you’re really signing up for (China policy risk, index-classification quirks, tracking a messy universe), the tax treatment, and how to size it. Figures verified against iShares and justETF, August 2026.

EIMI key facts

What does IMI add over the plain MSCI EM index?

The small-cap tier — roughly double the number of companies, and about 99% of each market’s investable equity instead of about 85%. You pay nothing extra for it: EIMI’s 0.18% is the same order as the non-IMI alternatives.

The standard MSCI Emerging Markets index holds ~1,400 large and mid caps. The IMI version adds the small-cap tier — roughly doubling the stock count and pushing coverage to ~99% of each market’s investable equity. Why it matters: EM small caps are more domestically driven (local consumption rather than global trade), historically less correlated with the mega caps, and precisely the segment stock-pickers claim as their hunting ground. Owning them by index at 0.18% quietly removes that argument. Practically: with EIMI you own Taiwan Semiconductor and the thousand small companies nobody in Europe can name — which is the point of indexing.

For the bigger picture, start with our ETF comparison hub.

Related: my Asia ETFs map covers this in depth.

Related: my China ETFs guide covers this in depth.

What’s actually inside

Expect roughly: China ~25–30%, India and Taiwan ~15–20% each, then Korea, Brazil, Saudi Arabia and the long tail — weights drift with markets, so check the current split on justETF before sizing. Top holdings are the EM mega caps: TSMC, Tencent, Samsung-tier names. Two structural quirks worth knowing:

• Korea and Taiwan are “emerging” by MSCI’s classification — developed economies kept in the EM bucket on market-access technicalities. A large slice of your “EM risk” is actually advanced-economy semiconductor exposure that overlaps thematically with funds like SMH.
• China is the elephant: policy decisions in Beijing move a quarter of the fund overnight. That’s not avoidable in honest EM indexing — it’s the asset class.

The case for and against an EM allocation

For

• Valuation and demographics: EM equities have spent years cheaper than developed markets while representing most of global growth in output and population.
• Diversification of regime: different rate cycles, different currencies, different winners — the point of adding EM is that it doesn’t move like the ~70%-US world index.
• Completeness: a world-only portfolio simply skips a fifth of global market cap. EIMI closes the gap in one line.

Against

• The last decade’s scoreboard: developed markets crushed EM for long stretches; cheapness alone is not a catalyst.
• Governance and policy risk are real and recurring — delistings, capital controls, regulatory shocks.
• You may own enough already: developed-market companies earn heavily in EM economies. The marginal diversification is smaller than the country labels suggest.

My position: 10–15% of equities in EM is a defensible, evidence-based allocation; zero is also defensible; 40% is a macro bet wearing an index costume. Consistency beats precision — pick a number and rebalance to it (my portfolio guide shows the mechanics).

Taxes and buying for EU investors

Standard Irish accumulating UCITS: nothing to declare annually in most EU countries until sale, treaty withholding handled inside the wrapper (EM markets each have their own withholding rules the fund absorbs — one more thing you outsource for 0.18%). Germany: Vorabpauschale with 30% equity exemption; Austria: OeKB reporting; Netherlands: Box 3. Buy the Xetra/Amsterdam line (EMIM) in euros or London (EIMI) in dollars — identical exposure; savings-plan eligible everywhere (setup guide). Full plumbing: UCITS explained.

EIMI vs the alternatives

vs Vanguard FTSE Emerging Markets: FTSE classifies Korea as developed — so the Vanguard fund excludes it and holds more China proportionally. Neither is wrong; just never mix MSCI-world with FTSE-EM (or vice versa) or Korea drops through the gap — the classification trap explained in my index guide.

vs plain (non-IMI) EM funds: marginally cheaper options exist without small caps; I consider the IMI breadth worth the basis points — it’s the “done properly” in this review’s title.

vs an all-world fund: if you hold VWCE or SPYI you already own EM at market weight (~10%); adding EIMI is an overweight decision, not a completion. With a developed-only core like XDWD, EIMI is the completion piece.

What to watch through 2026–2027

China’s weight and investability — index inclusion factors and delisting politics move the fund’s biggest slice. India’s ascent — steadily growing index share; EIMI captures it passively. Reclassification watch — Korea’s periodic developed-market candidacy would, if enacted, remove a top-three country from the index over a transition period; holders need do nothing but should understand why weights shifted.

Verdict

The best single tool for honest emerging-markets exposure in Europe: maximal breadth, sane fee, giant fund, clean wrapper. Size it at your chosen EM weight next to a developed core — and let it be boring. That’s what core funds are for.

Common mistakes with emerging-markets allocations

• Buying EM after it outperforms. The asset class runs in long regimes; chasing a hot year has historically been the worst entry. The boring fix: a fixed percentage, rebalanced annually, bought monthly.
• Mixing index families. MSCI world + FTSE emerging = Korea vanishes; FTSE developed + MSCI EM = Korea doubled. One family across your core — the classification trap explained.
• Doubling EM by accident: if your core is an all-world fund, it already holds ~10% EM. EIMI on top is an overweight decision — fine if intended, common as an accident.
• Panic-selling the China headlines. A quarter of the fund will always generate scary news. If policy risk in Beijing genuinely exceeds your tolerance, size EM smaller from the start — don’t discover the limit mid-selloff.

How EIMI behaves next to a developed core

The honest statistical picture: EM correlation with developed markets is high in crashes (diversification fails exactly when you want it) but meaningfully lower across full cycles — EM’s biggest decades happened while the US went sideways, and vice versa. That cycle-level divergence, not crash protection, is the diversification you’re buying. Currency adds a second layer: EM returns arrive in dollars-vs-EM-currencies terms, hedging is impractical and costly at this breadth, so the euro value breathes with FX. Over 15+ year horizons these currency swings have largely washed out; over 3-year horizons they dominate — one more reason EM allocations belong to patient capital only.

Sizing EM: the three schools, with numbers

Market weight (~10%): the neutral position — own the world as it is; an all-world fund does this automatically. GDP-weight tilt (20–30%): the valuation-and-growth argument — EM produces ~40% of world output but ~10% of market cap; tilters split the difference. Historically this required decade-long patience for its paydays. Zero: the “developed companies already earn there” school — defensible, though it forfeits the local-champion tier (TSMC has no developed-market substitute). On €50,000 of equities the practical difference between schools is €5,000–15,000 of EM — material, but dwarfed by the cost of switching schools mid-regime. Pick once, write down why, rebalance annually (mechanics here).

Reader scenarios: the EM questions my inbox actually gets

“VWCE holder — do I need EIMI?” No: you own EM at ~10% market weight already. EIMI is for two people: the XDWD-style developed-core holder completing the world, and the deliberate over-weighter pushing EM to 15–20%. If you can’t say which one you are, you’re neither — stay put.

“Is now a good time for EM? Valuations look cheap.” They’ve looked cheap for years — cheapness is a precondition, not a catalyst. The honest method: pick a strategic weight you’d hold through a bad decade, enter monthly, rebalance annually. If instead you’re timing a regime turn, that’s a trade — size it like one.

“What about a China-free EM fund?” They exist (EM ex-China UCITS funds) and solve a real preference — at the cost of removing the index’s largest market and its valuation case. Reasonable for investors with hard China constraints; for everyone else, sizing total EM smaller achieves similar risk relief with less index surgery.

“Why did my EM fund fall when the US fell? I bought it for diversification.” Crash correlation is the rule — diversification shows up across cycles, not within panics. The 2000s (EM boomed while the S&P went nowhere) is the pattern you’re actually buying; expect it on that timescale or not at all.

A decade with EIMI: the honest preview

Emerging markets test patience in a specific way developed markets don’t: the drawdowns come with narratives that sound structural — “governance will never improve,” “the dollar will always crush them,” “policy risk makes it uninvestable.” Sometimes those narratives are even briefly right. What history shows is regime rotation: multi-year stretches of dismal returns followed by explosive catch-ups concentrated in a few quarters — miss those quarters by market-timing and the asset class genuinely was pointless. The implementation answer is boring and absolute: a fixed weight, automated buying, annual rebalancing that mechanically adds during the despair phases (rebalancing mechanics). Do that and the fund’s 3,000-stock breadth does the rest; improvise, and no index construction can save the outcome.

For income-first EM investors: the dividend-screened counterpart to this broad exposure is reviewed in the iShares EM Dividend (SEDY) guide — a satellite income engine that pairs with, never replaces, EIMI-class breadth.

The dedicated overweight: India’s share of this fund grows mechanically — investors wanting deliberate extra weight should read the iShares MSCI India (NDIA) review, premium priced honestly.

Beyond the emerging tier: the frontier question — the thin shelf, the graduation pipeline this fund collects automatically — is mapped in the frontier markets guide.

Going deeper into one country: Brazil — commodities, banks and the rate cycle that drives its rallies — is reviewed in the MSCI Brazil (IBZL) guide.

Frequently asked questions

What is EIMI?

EIMI is the London ticker for the iShares Core MSCI Emerging Markets IMI UCITS ETF, ISIN IE00BKM4GZ66. It is a single Irish-domiciled, accumulating index fund holding over 3,000 emerging-market companies across 24 markets — large, mid and small caps — for 0.18% a year. On Xetra and Amsterdam the same fund trades in euros as EMIM. If you want emerging markets without choosing countries or managers, this is the default instrument.

How big is EIMI, and when did it launch?

EUR 37,658m at 26 August 2026, launched 30 May 2014 (justETF, IE00BKM4GZ66). That makes it one of the largest emerging-market funds available anywhere in the UCITS universe, with a twelve-year record. Size matters here for a specific reason rather than a general one: EM small caps are thinly traded, and a fund this large can run optimised sampling efficiently and keep spreads tight.

Is EIMI a good investment?

It is the right instrument if you have already decided to hold emerging markets; it does not decide that for you. As an instrument it is close to ideal: the broadest EM index on the shelf, 0.18%, EUR 37.7bn, Irish accumulating wrapper, physical replication. As an allocation, EM has underperformed developed markets for long stretches, a quarter to a third of the fund is Chinese policy risk, and cheapness has not been a catalyst. A defensible answer is 10-15% of your equities; another defensible answer is zero if your core is already an all-world fund holding EM at market weight. What is not defensible is buying it after a good year and selling it after a bad one.

Is EIMI accumulating or distributing?

This class accumulates. A distributing sibling exists in the iShares range for income investors.

EIMI or EMIM — which ticker do I buy?

Same fund, same ISIN: EIMI is the London USD line, EMIM trades in euros on Xetra and Amsterdam. Buy whichever your broker prices in your currency.

How much China is in the fund?

Roughly a quarter to a third depending on markets — check the live country breakdown on justETF before you size the position.

Does EIMI hold small caps?

Yes — that’s the IMI difference: large, mid and small caps, 3,000+ holdings, ~99% market coverage.

What EM percentage should I hold?

Market weight is ~10% of global equities; 10–15% of your equity allocation is the common-sense band. More than that is an active bet — make it consciously or not at all.

Does EIMI hedge currency risk?

No — you hold EM equities in their local currencies through a USD-calculated fund, and your euro returns include those FX moves. Hedged EM products exist but hedging two dozen partly-illiquid currencies is expensive; over long horizons unhedged has been the standard professional choice.

How does EIMI handle foreign-investor limits in markets like India?

Through the index provider’s foreign-inclusion factors — weights already reflect what foreigners can legally own. You will never need to act on access rules; that administration is precisely what the 0.18% pays for.

Is there a sustainable or ESG version of this exposure?

iShares and rivals run ESG-screened EM funds tracking filtered indices. Expect fewer stocks, different country tilts and slightly higher fees — a values choice layered on the same asset class. Compare the screened index’s country weights before assuming it behaves like EM IMI.

Sources

• justETF profile, IE00BKM4GZ66 — TER 0.18%, EUR 37,658m, Ireland, accumulating, inception 30 May 2014, read 26 August 2026
• MSCI Emerging Markets index page — the index family, country classification and the IMI definition
• iShares product page for EIMI — the KID, prospectus and daily holdings. Note that ishares.com returns HTTP 403 to automated requests; it opens normally in a browser.

Verify current fund figures before investing. Educational content, not financial advice.

Kestutis Balciunas
European UCITS/ETF investor with 11+ years building a global dividend and index portfolio, and founder of Financial Expert Class. I write every guide here from first-hand experience investing across EU brokers and tax regimes — not theory. More about me →